What is Paradigm Clinical Research?
Paradigm Clinical Research operates a sophisticated network of dedicated research clinics designed to streamline the clinical trial process for contract research organizations (CROs) and pharmaceutical sponsors. The company serves as a critical intermediary in the healthcare ecosystem, facilitating community-based participation in medical studies that are essential for drug development and therapeutic validation. By providing a robust infrastructure that supports trials of varying sizes and complexities, Paradigm enables medical professionals to transition into the role of investigators, thereby expanding the capacity for clinical innovation. Their model is built on the premise that accessible, high-quality research environments are fundamental to advancing the human condition and improving patient outcomes on a global scale.
How much funding has Paradigm Clinical Research raised?
Paradigm Clinical Research has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Paradigm Clinical Research
PPP
Public-Private Partnership
What's next for Paradigm Clinical Research?
With this late-stage capital, Paradigm Clinical Research is well-positioned to accelerate its growth trajectory by expanding its network of research sites and enhancing its technological capabilities for trial management. The strategic focus will likely shift toward optimizing patient recruitment pipelines and deepening partnerships with major CROs to handle increasingly complex therapeutic trials. As the clinical research landscape becomes more competitive, Paradigm's ability to leverage this investment to standardize high-quality data collection will be paramount. The company is expected to prioritize the integration of advanced digital tools to improve investigator efficiency and participant retention, ultimately cementing its role as a cornerstone of modern clinical trial infrastructure.
See full Paradigm Clinical Research company page
